Terms: = Lymphoma AND FOXP1, MGC12942, 27086, ENSG00000114861, hFKH1B, MGC99551, FLJ23741, QRF1, 12CC4, HSPC215, MGC88572 AND Diagnosis
14 results:
1. Indurated Plaques on the Legs: Think lymphoma.
Watts-Santos A; Cuellar-Barboza A; Ramos-Cavazos CJ; Villarreal-Martinez A; Ocampo-Candiani J; Herz-Ruelas ME
Acta Dermatovenerol Croat; 2021 Jul; 29(2):114-115. PubMed ID: 34477080
[TBL] [Abstract] [Full Text] [Related]
2. t(3;14)(p14.1;q32)/foxp1-IGH translocation in thyroid extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Sasaki Y; Shiozawa E; Watanabe N; Homma M; Noh JY; Ito K; Takimoto M; Yamochi-Onizuka T
Leuk Res; 2020 Aug; 95():106399. PubMed ID: 32534365
[TBL] [Abstract] [Full Text] [Related]
3. Novel markers in pediatric-type follicular lymphoma.
Agostinelli C; Akarca AU; Ramsay A; Rizvi H; Rodriguez-Justo M; Pomplun S; Proctor I; Sabattini E; Linch D; Daw S; Pittaluga S; Pileri SA; Jaffe ES; Quintanilla-Martinez L; Marafioti T
Virchows Arch; 2019 Dec; 475(6):771-779. PubMed ID: 31686194
[TBL] [Abstract] [Full Text] [Related]
4. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
[TBL] [Abstract] [Full Text] [Related]
5. Primary Cutaneous Diffuse Large B-Cell lymphoma, Leg Type, With Spontaneous Regression After Biopsy.
Marrero-Alemán G; Montenegro-Dámaso T; Peñate Y
Am J Dermatopathol; 2017 Oct; 39(10):785-787. PubMed ID: 28926365
[TBL] [Abstract] [Full Text] [Related]
6. [Application of rabbit monoclonal antibody GCET2 in diagnosis of diffuse large B cell lymphoma].
Pan HY; Zhang XX; Weng YY; Zhou R
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):844-849. PubMed ID: 28056299
[No Abstract] [Full Text] [Related]
7. Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and foxp1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.
Tzankov A; Leu N; Muenst S; Juskevicius D; Klingbiel D; Mamot C; Dirnhofer S
J Hematol Oncol; 2015 Jun; 8():70. PubMed ID: 26071053
[TBL] [Abstract] [Full Text] [Related]
8. Primary intravascular large B cell lymphoma of the endometrium.
Xia Y; Wang Y; Jiang Y; Yu W; Li Y; Xiang F; Wang C
Acta Histochem; 2014 Jun; 116(5):993-6. PubMed ID: 24418320
[TBL] [Abstract] [Full Text] [Related]
9. Indolent cutaneous B-cell lymphoma: diagnosis and treatment 2012.
Santucci M; Grandi V; Maio V; Delfino C; Alterini R; Pimpinelli N
G Ital Dermatol Venereol; 2012 Dec; 147(6):581-8. PubMed ID: 23149704
[TBL] [Abstract] [Full Text] [Related]
10. The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
Thieblemont C; Briere J; Mounier N; Voelker HU; Cuccuini W; Hirchaud E; Rosenwald A; Jack A; Sundstrom C; Cogliatti S; Trougouboff P; Boudova L; Ysebaert L; Soulier J; Chevalier C; Bron D; Schmitz N; Gaulard P; Houlgatte R; Gisselbrecht C
J Clin Oncol; 2011 Nov; 29(31):4079-87. PubMed ID: 21947824
[TBL] [Abstract] [Full Text] [Related]
11. foxp1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
Baró C; Espinet B; Salido M; Colomo L; Luño E; Florensa L; Ferrer A; Salar A; Campo E; Serrano S; Solé F
Histol Histopathol; 2009 Nov; 24(11):1399-404. PubMed ID: 19760589
[TBL] [Abstract] [Full Text] [Related]
12. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations].
Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526
[TBL] [Abstract] [Full Text] [Related]
13. New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma.
Adams H; Tzankov A; Lugli A; Zlobec I
J Clin Pathol; 2009 Nov; 62(11):986-97. PubMed ID: 18977805
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic markers and gene abnormalities in subgroups of diffuse large B-cell lymphoma: single center experience.
Korać P; Dominis M
Croat Med J; 2008 Oct; 49(5):618-24. PubMed ID: 18925695
[TBL] [Abstract] [Full Text] [Related]